HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of atenolol on coronary artery spasm after acute myocardial infarction in a Japanese population.

AbstractBACKGROUND:
Japanese patients with acute myocardial infarction (MI) have a greater incidence of coronary artery spasm than Caucasians. Some beta-blockers have been reported to aggravate coronary spasm. This study sought to assess the effects of beta-adrenoceptor blockade on coronary vasospasm in Japanese patients with acute MI who had been treated with primary angioplasty.
METHODS:
In 69 patients we analyzed the effect of atenolol 50 mg/day initiated the day after emergency primary angioplasty on the results of intracoronary ergonovine provocation test performed 4 weeks after onset.
RESULTS:
Among 35 patients in the atenolol group, the drug was discontinued in 9 (26%) due to hemodynamic compromise. The remaining 26 in the atenolol group and 34 in the control group underwent the spasm provocation test. Atenolol did not significantly increase the incidence of coronary vasospasm (31% vs. 15% in the atenolol and control groups, respectively, p= 0.135). Multivariate analysis revealed that only the pre-provocation diameter of the distal segment of the infarct-related artery predicted coronary spasm whereas atenolol did not.
CONCLUSIONS:
This study showed that atenolol 50 mg/day did not increase coronary spasm in Japanese acute MI patients. It is suggested that beta-blockers can be safely used soon after coronary intervention for acute MI without the risk of increasing coronary spasm; however, attention should be paid to hemodynamic change in the acute phase.
AuthorsManabu Shirotani, Ryoji Yokota, Ichiro Kouchi, Taku Hirai, Noritsugu Uemori, Kazunao Haba, Ryuichi Hattori
JournalInternational journal of cardiology (Int J Cardiol) Vol. 139 Issue 2 Pg. 181-6 (Mar 04 2010) ISSN: 1874-1754 [Electronic] Netherlands
PMID19019470 (Publication Type: Controlled Clinical Trial, Journal Article)
CopyrightCopyright 2008 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Adrenergic beta-Antagonists
  • Atenolol
  • Ergonovine
Topics
  • Adrenergic beta-Antagonists (administration & dosage)
  • Aged
  • Angioplasty, Balloon, Coronary
  • Asian People
  • Atenolol (administration & dosage)
  • Cohort Studies
  • Coronary Vasospasm (drug therapy, ethnology, etiology)
  • Ergonovine
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction (complications, ethnology, therapy)
  • Predictive Value of Tests
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: